AAM issues statement on President-elect Biden naming Katherine Tai as U.S. trade representative
WASHINGTON — The Association for Accessible Medicines and its members look forward to working with President-elect Biden’s U.S. Trade Representative (USTR)-designee Katherine Tai to ensure that U.S. trade policy promotes the proper balance between pharmaceutical innovation and off-patent competition that expands patient access to medicines and reduces health care costs. USTR-designee Tai was an instrumental leader
